Catherine Rycroft, PhD
Director, Clinical Evidence Review
Catherine joined BresMed in 2014 and has over 13 years of consultancy experience in market access, health economics and outcomes research, and medical communications.
She has a background in biological research, a PhD in Microbiology from the University of Reading, and spent 4 years working in molecular biology research for a biotech start-up. Catherine has a strong publication record, and extensive experience in medical writing, preparing market access deliverables (including global value dossiers, health technology assessment dossiers and systematic, structured and targeted literature reviews), and developing communication pieces such as manuscripts, slide sets, abstracts, posters and newsletters.
Catherine is part of our Clinical Evidence Review team and has been instrumental in developing the global value dossier arm of the business, along with associated value communication services.